| Type | Public (Euronext: GBT) |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1926 |
| Headquarters | Villepinte |
| Revenue | € 0.3 billion (2006) |
| Employees | 1,250 (2006) |
| Website | www.guerbet.com |
Guerbet is a research-centered pharmaceutical company based in France that is one of the major players in the contrast agents business.
The company's main products are:
The company is named after the French chemist Marcel Guerbet (1861–1938) , who produced Lipiodol in 1901 and his son Andre Guerbert, who founded the company in 1926. The X-ray contrast properties of Lipiodol were discovered in 1918.
|
|||||